Frontlight ResearchEarly access
Peripheral artery disease trials in South Korea
8 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEfficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Where
- Daegu, Seoul
- Age
- 18 years and over
- People
- 1,205 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07223593 · EU 2025-523283-21-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Anyang-si, Daegu, Gangnam-gu, Goyang-si, Guri-si, Gwangju, Ilsan-gu, Seoul, Wŏnju
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - Phase 4Taking peopleComparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy
- Where
- Seongnam-si
- Age
- 19 years and over
- People
- 2,758
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT07796217 - No phaseNot yet taking people in South KoreaIn-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)
- Where
- Yongin
- Age
- 20 years and over
- People
- 1,500
- Run by
- Yonsei University
See details and how to joinNCT07622485 - No phaseTaking peoplePressure Wire Guidance for Infrapopliteal Artery Interventions
- Where
- Seoul
- Age
- 19 years and over
- People
- 100
- Run by
- Yonsei University
See details and how to joinNCT06879561 - No phaseTaking peopleRandomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)
- Where
- Seoul
- Age
- 19 years to 80 years
- People
- 2,462
- Run by
- Yonsei University
See details and how to joinNCT06231966 - No phaseTaking peopleKorean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA): (A Retrospective & Prospective Observational Study)
- Where
- Seoul
- Age
- 20 years and over
- People
- 12,000
- Run by
- Yonsei University
See details and how to joinNCT02748226 - No phaseTaking peopleAsan Aorta and Peripheral Registry
- Where
- Seoul
- Age
- 19 years and over
- People
- 6,000
- Run by
- Asan Medical Center
See details and how to joinNCT06022653